Full-thickness resection of neuroendocrine tumors in the rectum

Endoscopy. 2020 Jan;52(1):68-72. doi: 10.1055/a-1008-9077. Epub 2019 Oct 15.

Abstract

Background: Rectal neuroendocrine tumors (NETs) are subepithelial tumors with potential for malignancy. Depending on tumor characteristics, endoscopic or surgical resection is recommended. However, the optimal endoscopic approach is not defined. This is the first larger study evaluating endoscopic full-thickness resection (EFTR) of rectal NETs.

Methods: For resection, the full-thickness resection device (FTRD) was used. A registry was created as part of post-market clinical follow-up. All cases of rectal NETs in the registry were analyzed retrospectively.

Results: 31 German centers entered data of 501 FTRD procedures and 40 cases of rectal NETs were identified. The median lesion size was 8 mm. All lesions could be resected using FTRD. The median procedure time was 18.5 minutes. Resection was macroscopically and histologically complete in all cases. Full-thickness resection was achieved in 95 %. No major adverse events occurred. Endoscopic follow-up showed no evidence of residual or recurrent tumor.

Conclusion: EFTR is safe and effective for resection of smaller rectal NETs. Prospective comparative trials are needed to define the role of EFTR of rectal NETs.

MeSH terms

  • Humans
  • Neoplasm Recurrence, Local
  • Neuroendocrine Tumors* / surgery
  • Prospective Studies
  • Rectum* / surgery
  • Retrospective Studies
  • Treatment Outcome